Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.2.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KR.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.49NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MF.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDK.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JQ.2.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.23.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DY.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LE.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MD.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LE.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDQNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.502NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.285NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.582NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.580NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.306NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.280NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.329NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.396NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.595.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.311NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.369NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.367NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.595NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.240NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.529 (Omicron)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.41.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.33 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.14.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.14.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1 (Omicron)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.17.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.99.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.52NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used